Answers are grounded in this paper and cite their sources.
Clinical manifestations of FMF at diagnosis with a M694V allele were predominantly influenced by the M694V rather than the second allele mutations. Although homozygous M694V was associated with the most severe form, the presence of compound heterozygosity with a VUS did not affect disease severity or clinical features. Homozygous M694V confers the highest risk of colchicine-resistant disease.
No takes yet. Share an insight, caveat, or question.
Kısaoğlu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: